Basit öğe kaydını göster

dc.contributor.authorDagoglu, Nergiz
dc.contributor.authorPatel, Vivek L.
dc.contributor.authorMahadevan, Anand
dc.date.accessioned2021-03-05T16:36:27Z
dc.date.available2021-03-05T16:36:27Z
dc.date.issued2015
dc.identifier.citationMahadevan A., Patel V. L. , Dagoglu N., "Radiation Therapy in the Management of Malignant Melanoma", ONCOLOGY-NEW YORK, cilt.29, ss.743-751, 2015
dc.identifier.issn0890-9091
dc.identifier.othervv_1032021
dc.identifier.otherav_c1794319-0112-4076-9764-8166b409d979
dc.identifier.urihttp://hdl.handle.net/20.500.12627/128399
dc.description.abstractThe initial treatment for primary and locoregional melanoma is surgery. Systemic therapy, and more recently immune therapy, has been the mainstay in the adjuvant and particularly the metastatic setting. Aside from palliation, there is a limited role for definitive radiation therapy for melanoma. However, in the adjuvant setting, postoperative radiation can improve locoregional disease control, albeit with potential toxicity and limited survival benefit. Stereotactic radiosurgery plays a vital role in the treatment of limited brain and extracranial metastasis.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleRadiation Therapy in the Management of Malignant Melanoma
dc.typeMakale
dc.relation.journalONCOLOGY-NEW YORK
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume29
dc.identifier.issue10
dc.identifier.startpage743
dc.identifier.endpage751
dc.contributor.firstauthorID225158


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster